(lp0
S'Novelion Therapeutics Reports Preliminary Fourth Quarter &amp; Full Year 2016 ... GlobeNewswire  - Mar 15, 2017 VANCOUVER, British Columbia, March 15, 2017  -- Novelion Therapeutics Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases ... Pro forma net ...Novelion Therapeutics Inc.  Files An 8-K Results of Operations ... - Market ExclusiveNovelion Therapeutics reports 4Q loss - Yahoo Finance'
p1
aS'Novelion Therapeutics Observes Rare Disease Day GlobeNewswire  - Feb 28, 2017 28, 2017  -- Novelion Therapeutics Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today announced today its alliance with the National ...'
p2
aS'Novelion Therapeutics Inc.  Files An 8-K Other Events Market Exclusive - Mar 7, 2017 Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases.Novelion Therapeutics  Lomitapide Patents Affirmed with Favorable IPR ... - StreetInsider.comNovelion prevails in challenge to lomitapide patents - Seeking Alpha'
p3
aS'Novelion Therapeutics to Announce Preliminary Fourth Quarter and Full Year ... GlobeNewswire  - Mar 13, 2017 VANCOUVER, British Columbia, March 13, 2017  -- Novelion Therapeutics Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today&nbsp;...'
p4
aS'Novelion Therapeutics Announces Presentation at the 29th Annual ROTH Conference GlobeNewswire  - Mar 8, 2017 VANCOUVER, British Columbia and CAMBRIDGE, Mass., March 08, 2017  -- Novelion Therapeutics, Inc.  , a biopharmaceutical company dedicated to developing new standards of care for individuals living&nbsp;...'
p5
aS'Analysts Anticipate Novelion Therapeutics Inc.  to Post  EPS The Cerbat Gem - Feb 19, 2017 Novelion Therapeutics logo Novelion Therapeutics Inc.   has been assigned an average broker rating score of 2.00  from the two brokers that provide coverage for the company, Zacks Investment Research reports.'
p6
aS'Investor Watch on Shares of Novelion Therapeutics Inc.  SKV News - 11 hours ago Novelion Therapeutics Inc.  currently has a 6 month price index of 1.44000. The six month price index is easily measured by dividing the current share price by the share price six months ago.'
p7
aS'The Brokerages Anticipate Novelion Therapeutics Inc  to Announce ($0.50 ... Petro Global News 24 - Mar 15, 2017 Shares of Novelion Therapeutics Inc   have earned an average broker rating score of 2.00  from the two brokers that cover the stock, Zacks Investment Research reports.'
p8
aS"Flexion Therapeutics: Novel Knee Osteoarthritis Therapy With Upcoming Catalyst Seeking Alpha - Feb 24, 2017 The company's flagship product candidate, Zilretta is an injectable, extended-release, intra-articular formulation of triamcinolone acetonide, a corticosteroid that is being developed for the treatment of patients with knee osteoarthritis."
p9
aS"TG Therapeutics, Inc. Announces Preclinical Data Presentation at the 2017 ... GlobeNewswire  - 17 hours ago NEW YORK, March 20, 2017  -- TG Therapeutics, Inc. , today announced that preclinical data for the Company's anti-PD-L1 monoclonal antibody, has been selected for presentation at the upcoming American Association for Cancer ..."
p10
a.